Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy

GAN Yu-liang1; JIAO Dan2; LIU Wen-feng1

doi:10.13422/j.cnki.syfjx.2010.06.014

您当前的位置：

首页 >

文章列表页 >

Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy

更新时间：2024-09-23

- Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 6, Pages: 253-255(2010)
- 作者机构：
  
  1. 酒泉市第二人民医院
  2. 酒泉市医院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.06.014
  CLC： R273
- Published：2010
- 稿件说明：
移动端阅览
[1]甘雨良,焦丹,刘文峰.四君子汤加减联合化疗治疗胃肠道恶性肿瘤多药耐药基因阳性病例[J].中国实验方剂学杂志,2010,16(06):253-255.

GAN Yu-liang1, JIAO Dan2, LIU Wen-feng1. Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(6): 253-255.
[1]甘雨良,焦丹,刘文峰.四君子汤加减联合化疗治疗胃肠道恶性肿瘤多药耐药基因阳性病例[J].中国实验方剂学杂志,2010,16(06):253-255. DOI： 10.13422/j.cnki.syfjx.2010.06.014.

GAN Yu-liang1, JIAO Dan2, LIU Wen-feng1. Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(6): 253-255. DOI： 10.13422/j.cnki.syfjx.2010.06.014.

摘要

目的:观察四君子汤加减联合化疗综合治疗胃肠道恶性肿瘤多药耐药基因阳性患者的疗效。方法:采用免疫组化的方法对本院近几年117例胃肠道恶性肿瘤标本予以多药耐药基因的检测

并对其中多药耐药基因阳性的55例患者用四君子汤加减联合化疗进行了治疗研究

其中治疗组28例

用化疗的同时

服用四君子汤加减治疗;对照组27例

只采用化疗。结果:中药加化疗组患者化疗过程中毒副反应明显轻于单纯化疗组

完成化疗率96.4%。单用化疗组由于白细胞减少或消化道反应严重而中止化疗

能完成化疗者只占70.4%;治疗组Ⅰ

Ⅱ

Ⅲ期5年生存期分别为75.0%

63.6%

22.2%

对照组Ⅰ

Ⅱ

Ⅲ期5年生存期分别为55.6%

37.5%

10.0%。结论:四君子汤加减联合化疗对胃肠道恶性肿瘤多药耐药基因阳性病例具有明显的临床疗效。

Abstract

Objective:To observe the therapeutic effect of Sijunzitang with chemotherapy in treating gastrointestinal cancer multidrug resistance gene-positive patients.Method:By immunohistochemical methods in our hospital 117 cases of gastrointestinal cancer pathology specimens for detection of multidrug resistance gene

and multidrug resistance gene in which 55 patients were positive for clinical studies

treatment group 28 cases

using Sijunzitang combined with chemotherapy for treatment;the control group 27 cases

only with chemotherapy.Result:Toxic side-effects in patients treated by Sijunzitang combined with chemotherapy were significantly lower than that in chemotherapy group

the completion of chemotherapy rate was 96.4%.In chemotherapy alone group

due to neutropenia or serious gastrointestinal response and chemotherapy had been suspended for some cases

to completion rate was only 70.4%.The treatment group Ⅰ

Ⅱ

Ⅲ period of 5 years survival were 75.0%

63.6%

22.2%

while the control group were 55.6%

37.5%

10.0%.Conclusion:Sijunzitang with chemotherapy has definite effect for the treatment of gastrointestinal tract cancer multidrug resistance gene-positive cases.

关键词

Keywords

references

Views

181

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of Gastrointestinal Cancer Multidrug Resistance Gene-positive Cases by Sijunzitang with Chemotherapy

Observation of Wenshen Kaiyu Tongbi Tang on Chest Stuffiness and Pain with Heart-kidney Yang Deficiency

Related Author

GAN Yu-liang

JIAO Dan

LIU Wen-feng

GAO Zheng

LIU Yin-wei

ZHANG Cui-yue

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰